| 7.97 Data as of Jun 18 |  -0.06 / -0.75%Today’s Change | 7.44 Today|||52-Week Range 12.83 | -24.24% Year-to-Date |
| Symmetry Provides Dismal 2013 View - Analyst Blog Jun 11 / Zacks.com | Why Symmetry Medical Shares Plunged Jun 11 / MotleyFool.com |
| Previous close | 8.03 |
| Today’s open | 8.03 |
| Day’s range | -- - -- |
| Volume | 418,192 |
| Average volume (3 months) | 281,489 |
| Market cap | $297.1M |
| Dividend yield | -- |
| Earnings growth (last year) | +212.50% |
| Earnings growth (this year) | +3.86% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +14.33% |
| P/E ratio | 36.2 |
| Price/Sales | 0.91 |
| Price/Book | 0.93 |
| Today’s change | Today’s % change | |
|---|---|---|
| ELOSSyneron Medical Ltd | +0.10 | +1.18% |
| UNISUnilife Corp | +0.03 | +0.96% |
| CERSCerus Corp | 0.00 | 0.00% |
| SRDXSurModics Inc | +0.35 | +1.52% |
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | $0.15 |
| Annual revenue (last year) | $410.5M |
| Annual profit (last year) | $9.1M |
| Net profit margin | 2.21% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer, Director & SVP Thomas J. Sullivan, MBA |
CFO, Senior VP & Head-Investor Relations Fred L. Hite |
Corporate headquarters Warsaw, Indiana |
.
